Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
vivo porcine tissues subjected to controlled enzymatic degradation (collagenase, elastase) will be used as a reproducible experimental proxy. While this approach does not reproduce the full endocrine
-
, understanding degradation mechanisms, and improving electrochemical performance. The postdoc will work with state-of-the-art facilities for materials synthesis, structural and electrochemical characterization
-
la carence en œstrogènes. Des essais mécaniques en traction uniaxiale et biaxiale, ainsi que des tests orientés vers la rupture, permettront de caractériser les comportements hyperélastiques
-
Deadline: 21 January 2026 Details Most microbes continually modify their chemical environment through metabolic processes such as consumption of oxygen and degradation of complex organic matter
-
the obtained genetic information. 2. Cultivation of plastic-degrading microorganisms and characterization of plastic-degrading enzymes. Common tasks 3. Biodegradation tests and various sampling activities in
-
Commissariat à l'Energie Atomique et aux Energies Alternatives - Groupe | Gif sur Yvette, le de France | France | about 2 hours ago
the bulk. Modest γ-radiation can degrade FeCAP polarization [Zhang2020], however, the reported resilience metrics do not include FeRAM at the memory array-level with large statistical data collection
-
will investigate how AI and real-time data analytics can be leveraged to accurately predict battery degradation, optimize charging and discharging cycles, and facilitate dynamic energy scheduling in
-
to incorporation into short stacks for durability testing. This post will be directed towards the development of high performance and degradation resistant electrode materials for use in either oxide ion conducting
-
. The position spans electrochemical testing, modeling, microstructural analysis, and collaborative research in an international environment. Your primary tasks will be to Conduct degradation studies to uncover
-
Leukemia DC15: Novel preclinically-validated GATA3 inhibitor/degrader as a therapy for T-cell Acute Lymphoblastic Leukemia DC16: Targeting Metabolic Pathways in Leukemic Stem Cells for AML Treatment